Analysis of clinicopathologic factors in malignant mixed Müllerian tumors of the uterine corpus

International Journal of Gynecological Cancer

Volumn 12, Issue 4, 2002, Pages 348-353

  Inthasorn, P ^a,c   Carter, J ^a,b   Valmadre, S ^a   Beale, P ^a   Russell, P ^a   Dalrymple, C ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Mixed M llerian tumor; Uterine corpus

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MIXED MULLERIAN TUMOR; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; UTERUS CANCER;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MENOPAUSE; MIDDLE AGED; MIXED TUMOR, MULLERIAN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEW SOUTH WALES; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; UTERINE NEOPLASMS;

EID: 0036326732     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2002.01117.x     Document Type: Article

References (22)

1. Uterine carcinomsarcomas. Incidence and trends in managment and survival
2. Treatment of uterine leiomyosarcoma
3. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma
4. Assessing obesity. Classification and epidemiology
5. Sarcoma of the uterus: A clinical study of 42 patients
6. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases
7. Carcinosarcoma of the uterus: A clinicopathological multicenter CTF study
8. The impact of adjuvant radiotherapy on carcinosarcoma of the uterus
9. Uterine sarcoma: The Curie Institute experience. Prognostic factors and adjuvant treatments
10. Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus
11. Prognostic factors in uterine carcinosarcoma
12. An excess of uterine sarcomas after pelvic irradiation
13. Prognostic factors in early stage uterine sarcoma: A Gynecologic Oncology Group study
14. Mixed mullerian tumor of the uterus: A clinicopathologic study
15. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma
16. Brief report: Cerebral metastasis from a malignant mixed mullerian tumor
17. Clinicopathologic analysis of uterine malignant mixed Mullerian tumors
18. Prognostic value of peritoneal washings in patients with malignant mixed mullerian tumors of the uterus
19. The role of whole-pelvic irradiation in the treatment of earlystage uterine carcinosarcoma
20. Results of post operative radiotherapy in the treatment of sarcoma ofcorpus uteri
21. A randomized clinical trial of adjuvant Adriamycin in uterine sarcomas: A Gynecologic Oncology Group study
22. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group study